Anthony G. Busa, Jr., has been named chief executive officer of CEDRA Corp., a division of Worldwide Clinical Trials (WCT) and a provider of Phase I clinical research and bioanalytical services. Mr. Busa has more than 34 years of experience in management positions including senior level management, regional and national sales and product development within the pharmaceutical and medical device industries. Previously, he held senior management related positions at McClintic Busa Group, LLP, dg...